» Articles » PMID: 39090109

Revealing the Crucial Roles of Suppressive Immune Microenvironment in Cardiac Myxoma Progression

Overview
Date 2024 Aug 1
PMID 39090109
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac myxoma is a commonly encountered tumor within the heart that has the potential to be life-threatening. However, the cellular composition of this condition is still not well understood. To fill this gap, we analyzed 75,641 cells from cardiac myxoma tissues based on single-cell sequencing. We defined a population of myxoma cells, which exhibited a resemblance to fibroblasts, yet they were distinguished by an increased expression of phosphodiesterases and genes associated with cell proliferation, differentiation, and adhesion. The clinical relevance of the cell populations indicated a higher proportion of myxoma cells and M2-like macrophage infiltration, along with their enhanced spatial interaction, were found to significantly contribute to the occurrence of embolism. The immune cells surrounding the myxoma exhibit inhibitory characteristics, with impaired function of T cells characterized by the expression of GZMK and TOX, along with a substantial infiltration of tumor-promoting macrophages expressed growth factors such as PDGFC. Furthermore, in vitro co-culture experiments showed that macrophages promoted the growth of myxoma cells significantly. In summary, this study presents a comprehensive single-cell atlas of cardiac myxoma, highlighting the heterogeneity of myxoma cells and their collaborative impact on immune cells. These findings shed light on the complex pathobiology of cardiac myxoma and present potential targets for intervention.

References
1.
Smits P, Li P, Mandel J, Zhang Z, Deng J, Behringer R . The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell. 2001; 1(2):277-90. DOI: 10.1016/s1534-5807(01)00003-x. View

2.
Gosev I, Paic F, duric Z, Gosev M, Ivcevic S, Bulic Jakus F . Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol. 2012; 164(1):7-20. DOI: 10.1016/j.ijcard.2011.12.052. View

3.
Sun X, Fu X, Xu S, Qiu P, Lv Z, Cui M . OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer. Int Immunopharmacol. 2021; 101(Pt B):108275. DOI: 10.1016/j.intimp.2021.108275. View

4.
Butler A, Hoffman P, Smibert P, Papalexi E, Satija R . Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018; 36(5):411-420. PMC: 6700744. DOI: 10.1038/nbt.4096. View

5.
Swartz M, Lutz C, Chandan V, Landas S, Fink G . Atrial myxomas: pathologic types, tumor location, and presenting symptoms. J Card Surg. 2006; 21(4):435-40. DOI: 10.1111/j.1540-8191.2006.00265.x. View